This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: The Innovations of Frieder Gnad
Introduction
Frieder Gnad is a notable inventor based in Bad Kreuznach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for manufacturing important compounds. With a total of 2 patents to his name, Gnad's work has had a meaningful impact on medical advancements.
Latest Patents
Gnad's latest patents include a process for the manufacture of dabigatran etexilate. This improved process not only enhances the preparation of dabigatran etexilate but also addresses analogous compounds of formula 7. His innovative approach in this area showcases his commitment to advancing pharmaceutical manufacturing techniques.
Career Highlights
Frieder Gnad is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to leverage his expertise in drug development and contribute to the creation of life-saving medications. Gnad's dedication to his work is evident in the quality and relevance of his patents.
Collaborations
Throughout his career, Gnad has collaborated with esteemed colleagues such as Stefan Schmitt and Hermann Mueller-Boetticher. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Frieder Gnad is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in the field. His contributions, particularly in the manufacturing of dabigatran etexilate, highlight his role as a key player in medical innovation.